Navigation Links
European Molecular Diagnostic Market for Group A Streptococcus (GAS) Nucleic Acid (NA) Test Products Projected to Reach US$ 22.3 Mn in 2023: TMR
Date:5/6/2016

ALBANY, New York, May 6, 2016 /PRNewswire/ --

According to a new market report published by Transparency Market Research "Molecular Diagnostic Market for Group A Streptococcus (GAS) Nucleic Acid (NA) Test Products Market - Europe Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2015 - 2023", the Europe molecular diagnostic market for group A streptococcus (GAS) nucleic acid (NA) test products market was valued at US$ 8.3 Mn in 2014 and is projected to expand at a CAGR of 11.6% from 2015 to 2023 to reach US$ 22.3 Mn in 2023.

Rapid and accurate diagnosis is a key factor for effective disease treatment. Increasing incidence of Streptococcus pyogenes infection in Europe, advancement of technology, and rising demand for point-of-care testing act as a high impact drivers of the market. Advancements in techniques such as isothermal nucleic acid amplification tests is likely to propel the market during the forecast period. The molecular diagnostic market for group A streptococcus (GAS) nucleic acid (NA) test in Europe has been segmented based on type of test technique, end-user, and region.

Download Industry Research Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=10505

A study conducted by the American Society for Microbiology concluded that incidence rate of Streptococcus pyogenes is high in countries in Northern Europe. The incidence of the disease has increased at a steady rate in most of these countries of the market. The automated detection system offers a faster, more flexible, and cost-effective solution to clinicians. Advancement of technology is bringing testing services to point-of-care. Due to its high sensitivity and accuracy the tests are backs up all negative rapid antigen assays. The Advancements in nucleic acid testing technologies and their adoption in Europe would result in high growth adoption of the technology will primarily occur in the developed countries. Ineffectiveness and slow adoption are the major restraints of the market.

The polymerase chain reaction segment held the largest share of the market in 2014, followed by the non-amplified tests segment. PCR is a traditional technology used for nucleic acid tests. However, the new, efficient, and user-friendly methods, such as isothermal nucleic acid amplification and non-amplified tests, are likely to capture higher market share in the near future. Isothermal nucleic acid amplification technology has been identified as the fastest growing segment during the forecast period due to its accuracy and rapid identification. Nucleic acid amplification techniques take tiny amounts of DNA or RNA, replicate them many times, and thus can detect minute traces of an organism in a specimen, avoiding the need for culture. Non-amplified technology using hybridization probe would capture a decent share in the market during the forecast period.

Browse Research Report: http://www.transparencymarketresearch.com/europe-molecular-diagnostic-market.html

The hospitals end-user segment accounted for over 58.2% share of the nucleic acid (NA) test products market in Europe in terms of revenue in 2014, followed by the public health laboratories segment. Moreover, the segment is expected to gain market share and emerge as the fastest growing segment during the forecast period.

Western Europe was the largest market for nucleic acid (NA) test products in 2014, accounting for around 48.9% share. Western Europe dominated the market due to highly developed health care infrastructure and favorable reimbursement scenario. On the other hand, Northern Europe is expected to gain high market share during the forecast period owing to increase in incidence of Streptococcus pyogenes infection and high adoption rate.

Browse Regional PR: http://www.europlat.org/european-molecular-diagnostic-market.htm

Market Players: 

Alere, Inc., F. Hoffmann-La Roche Ltd., Hologic, Inc., Meridian Bioscience, Inc., Nanosphere, Inc., and Quidel Corporation are the major players operating in European Molecular Diagnostic Market for Group A Streptococcus (GAS) Nucleic Acid (NA) Test Products market.

Other Reports by TMR: 

  • Separation Systems for Commercial Biotechnology Market:  

http://www.transparencymarketresearch.com/separation-systems-commercial-biotechnology-market.html

  • Metabolomics Market:  

http://www.transparencymarketresearch.com/metabolomics-market.html

  • In-vitro Colorectal Cancer Screening Tests Market:  

http://www.transparencymarketresearch.com/in-vitro-colorectal-cancer-screening-tests-market.html

About Us:  

Transparency Market Research (TMR) is a U.S. based provider of syndicated research, customized research, and consulting services. TMR's global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact:

Mr. Sudip. S
90 State Street, Suite 700
Albany, NY 12207
United States.
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

Blog: http://www.tmrblog.com/


'/>"/>
SOURCE Transparency Market Research
Copyright©2016 PR Newswire.
All rights reserved


Related biology technology :

1. Janssen Announces Data from Simeprevir in Hepatitis C Patients Will Be Presented at The International Liver Congress of the European Association for the Study of the Liver (EASL)
2. European Bioplastics publie des données sur lutilisation des terres pour les bioplastiques
3. mPhase Technologies, Inc. Commencing Discussions with Major European Drug Company for Drug Delivery System
4. GenoVive, a pioneer in DNA-based weight management solutions, today announced the companys first European partnership as of May 1, 2013 with DNADIETA based in Poland.
5. European Inventor Award 2013 Goes to Outstanding Inventors From Austria, France, Sweden, Switzerland, Spain and the US
6. GSMA: The Adoption Of mHealth Could Reduce Total Annual European Healthcare Spend By Almost Euro 100 Billion In 2017
7. Amgen And AstraZeneca Highlight Data To Be Presented At European League Against Rheumatism Annual Meeting
8. Brazils UNICA Statement on European Parliament Vote Outcome on Biofuels/ILUC
9. PTC Therapeutics to Present at European Pediatric Neurology Society Congress
10. Market Study MBT - The European Market for Mechanical Biological Treatment Plants
11. MD Biosciences Publishes the Characterization of a Porcine Model of Post-operative Or Incisional Pain in the European Journal of Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... -- Kineta, Inc., a biotechnology company focused on ... today announced the discovery and characterization of several ... interferon response factor 3 (IRF3) via RIG-I like ... in a murine colon carcinoma mouse model.  Furthermore, ... regression to initial drug treatment were resistant to ...
(Date:3/23/2017)... 23, 2017  Agriculture technology company Cool Planet has ... note conversion to commercialize its Cool Terra and Cool ... developing products that are simultaneously profitable as well as ... last 18 months. This latest round of funding was ... The company,s primary product, Cool Terra, ...
(Date:3/22/2017)... Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), today announced a ... Biobank and GSK to generate genetic sequence data from the ... will enable researchers to gain valuable insights to support advances ... of serious and life threatening diseases. ... Genetic evidence has revolutionized ...
(Date:3/22/2017)... March 22, 2017  UBM and the Massachusetts ... their extended partnership and the third annual Massachusetts Medtech ... the 21 st Annual MassMEDIC Conference held ... May 3-4, 2017. MassMEDIC will ... (ADVAMED) President and CEO, Scott Whitaker , ...
Breaking Biology Technology:
(Date:3/23/2017)... -- Research and Markets has announced the addition of ... Industry Forecast to 2025" report to their offering. ... The Global Vehicle Anti-Theft ... 8.8% over the next decade to reach approximately $14.21 billion by ... and forecasts for all the given segments on global as well ...
(Date:3/20/2017)... , March 20, 2017 At this year,s CeBIT ... -based biometrics manufacturer DERMALOG. The Chancellor came to the DERMALOG stand together ... is this year,s CeBIT partner country. At the largest German biometrics company ... use: fingerprint, face and iris recognition as well as DERMALOG´s multi-biometrics system.   ... ...
(Date:3/9/2017)... Australia , March 9, 2017 ... the prestigious World Lung Imaging Workshop at the University ... , was invited to deliver the latest data to ... globally recognised event brings together leaders at the forefront ... developments in lung imaging. "The quality ...
Breaking Biology News(10 mins):